Robert Kramer

2021 - Emergent BioSolutions

In 2021, Robert Kramer earned a total compensation of $6.9M as President, Chief Executive Officerand Director at Emergent BioSolutions, a 24% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$900,000
Option Awards$2,198,742
Salary$1,026,924
Stock Awards$2,800,026
Other$6,385
Total$6,932,076

Kramer received $2.8M in stock awards, accounting for 40% of the total pay in 2021.

Kramer also received $900K in non-equity incentive plan, $2.2M in option awards, $1M in salary and $6.4K in other compensation.

Rankings

In 2021, Robert Kramer's compensation ranked 1,776th out of 12,406 executives tracked by ExecPay. In other words, Kramer earned more than 85.7% of executives.

ClassificationRankingPercentile
All
1,776
out of 12,406
86th
Division
Manufacturing
655
out of 5,494
88th
Major group
Chemicals And Allied Products
243
out of 2,369
90th
Industry group
Drugs
205
out of 2,090
90th
Industry
Pharmaceutical Preparations
139
out of 1,537
91st

Pay ratio

Robert Kramer's Pay$6,932,076
Median Employee's Pay$110,416
Pay Ratio

63

to 1

In 2021, the annual total compensation of Robert Kramer was $6,932,076.

The annual total compensation of the median employee at Emergent BioSolutions was $110,416.

The ratio of Robert Kramer's pay to the pay of median employee was therefore 63 to one.

Source: SEC filing on April 15, 2022.

Kramer's colleagues

We found four more compensation records of executives who worked with Robert Kramer at Emergent BioSolutions in 2021.

2021

Fuad El-Hibri

Emergent BioSolutions

Chairman

2021

Richard Lindahl

Emergent BioSolutions

Chief Financial Officer

2021

Adam Havey

Emergent BioSolutions

Chief Operating Officer

2021

Atul Saran

Emergent BioSolutions

Executive Vice Presidentand Chief Strategy andand Development Officer

News

You may also like